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Introduction 
 Pleural effusions may occur as a complication of primary 
tuberculosis or an established pulmonary or extrapulmonary infection.  
New formation or expansion of a tuberculous lesion during chemotherapy  
is referred to as paradoxical response.  Paradoxical response has been 
described to occur weeks or months after starting antituberculous 
chemotherapy for parenchymal lung disease, intracranial tuberculoma, or 
pleural effusion1-2.  
 To our knowledge only one case of contralateral paradoxical effusion that occurred eight weeks after 
standard antituberculous chemotherapy has been reported in the literature3.  In this paper, we describe 
a patient who developed contralateral paradoxical pleural effusion six days after standard 




 23-year Asian lady was admitted to 
our ward (City General Hospital, 
Stoke-on-Trent) with a three weeks 
history of shortness of breath on moderate 
exertion, cough productive of white sputum, 
night sweats, and one stone weight loss.  
Clinical examination was normal except for 
signs of left pleural effusion; this was 
confirmed on X-ray of the chest (plate 1). The 
full blood count showed haemoglobin of 8.9 
g/dl, white blood cell count 6.2 x 109/l, mean 
corpuscular volume 53.9 fl, mean corpuscular 
haemoglobin 17.1 pg (patient is known 
thalassaemia trait). The ESR was 55mm/hr and 
the C - reactive protein was raised at 171 mg/l.  
At thoracocentesis straw coloured fluid was 
aspirated.  The fluid was an exudate: protein 
content was 56 g/l.  The Gram stain was 
negative.  A pleural biopsy obtained at the 
time of thoracocentesis, showed several foci of 
caseous necrosis surrounded by palisaded 
histeocytes with scattered langhans cells; 
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The pleural effusion was drained to dryness 
and the patient was started on standard 
antituberculous treatment with rifampicin, 
isoniazid, and pyrazinamide, in addition to 
pyridoxine and prednisolone 30 mgs per day.  
The patient improved clinically and her 
temperature was normal before she was 






 Although chemotherapy was not 
interrupted at any time, the patient was 
readmitted three days after discharge (six days 
after initiation of anti tuberculous therapy) 
with feeling cold and shivery and had right 
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side pleuritic chest pain and headache.  
Physical examination revealed: temperature 
raised at 380C and there were signs of right 
side pleural effusion which was confirmed on 
X-ray of the chest (plate 2).  Full blood count 
had not changed.  Liver function test showed a 
slightly raised Gamma Glutamyl transferase at 
38 U/L (normal 0 - 35), and the CRP was 178 





Atituberculous chemotherapy and 
prednisolone were continued.  Thoracocentesis 
was not performed on this admission.  The 
patient continued to have high temperature for 
six days; this eventually settled and she was 
discharged home after seven days of 
hospitalization on rifampicin, isoniazid, 
pyrazinamide, pyridoxine and 30 mg 
prednisolone.  The prednisolone was continued 
for further four weeks and stopped after 
gradual reduction over 20 days.  The patient 
was followed-up in clinic and after two 
months of treatment the chest X-ray was 




     Modern chemotherapy regimens for the 
treatment of tuberculosis are associated with 
high level of effectiveness and minimal side 
effects4.  Paradoxical worsening of pleural 
effusions has, however, been described1-3, 5.  A 
survey reported an incidence of 16% among 
61 patients with tuberculous pleural effusions5.  
The mechanisms by which paradoxical 
response occur are speculative. 
 




In the past such response was thought to result 
from rupture into the pleural space of 
subpleural caseous foci, mediastinal lymph 
nodes, or haematogenous dissemination, and 
mycobacterium was cultured from pleural 
fluid several weeks after initiation of therapy.  
In recent years, however, this response is 
thought to represent local manifestations of 
heightened delayed hypersensitivity mounted 
against immunogenic cell wall substances 
resealed from dying tuberculous bacilli in 
patients whose level of cellular immunity is 
enhanced as a result of chemotherapy6. 
  Two points, however, deserve special 
discussion in this case.  Firstly, contralateral 
effusion developed only six days after 
initiation of treatment whereas a previous case 
report has shown this to occur many weeks 
after starting therapy3.  It would, therefore, be 
important to consider such a reaction in the 
differential diagnosis of patients who develop 
new symptoms soon after initiation of 
antituberculous chemotherapy.  Secondly, our 
patient was taking prednisolone when she 
developed the paradoxical pleural effusion.  
Although steroids are known to modify the 
severity of clinical manifestations of 
tuberculosis, it has clearly failed to prevent the 
paradoxical response in this patient.   
 
Interestingly, the only case of paradoxical 
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response reported in the literature was also 
taking prednisolone3.  What we can not be 
certain of is whether the prednisolone has 
reduced the severity of reaction in these two 
patients.  Indeed, the pleural effusion that 
developed in the patient we report was not 
large and required no drainage.  In the series 
reported by Al-Majed5 six of ten patients who 
developed paradoxical worsening of their 
effusion had respiratory distress with massive 
effusions requiring pleural aspirations; none of 
these patients were taking steroids at the time 
of presentation. Clearly a prospective placebo-
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